InvestorsHub Logo
Followers 33
Posts 2911
Boards Moderated 1
Alias Born 10/24/2015

Re: None

Friday, 10/01/2021 12:15:42 PM

Friday, October 01, 2021 12:15:42 PM

Post# of 155
SITC titles (presented jointly with CRSP):

A Combined Strategy of CD70 CAR Co-expression with Membrane-bound IL-15 and CISH Knockout Results in Enhanced NK Cytotoxicity and Persistence
Abstract Number and Type:
16439, oral*
Poster Presentation Date and Time:
November 10, 2021, 2:40 p.m. ET

CISH Gene-knockout Anti-CD70-CAR NK Cells Demonstrate Potent Anti-tumor Activity Against Solid Tumor Cell Lines and Provide Partial Resistance to Tumor Microenvironment Inhibition
Abstract Number and Type:
113, poster
Poster Presentation Date and Time:
November 12, 2021, 7:00 am – 8:30 pm ET

NKTX presentations:

Potentiating the Large-Scale Expansion and Engineering of Peripheral Blood-Derived CAR NK Cells for Off-the-Shelf Application
Abstract Number and Type:
151, poster
Poster Presentation Date and Time:
November 12, 2021, 7:00 am – 8:30 pm ET

KIR Haplotype Can Inform Donor Selection in the Production of Allogeneic Memory-Like CAR NK Cells for Clinical Application
Abstract Number and Type:
128, poster
Poster Presentation Date and Time:
November 13, 2021, 7:00 am – 8:30 pm ET
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKTX News